A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Electric vehicle owners could earn thousands by supporting power grid
2
Neanderthal infants were enormous compared with modern humans
3
How to spot the Lyrid meteor shower tonight
4
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
5
Largest ever map of universe captures 47 million galaxies and quasars
6
My life as a meteorologist in Chernobyl under Russian occupation
7
Collapse of key ocean current may release billions of tonnes of carbon
8
Computer finds flaw in major physics paper for first time
9
The rise, the fall and the rebound of cyclic cosmology
10
The first quantum computer to break encryption is now shockingly close
